<h3>Thesis References</h3>
<ul>
    <li>Drilling into the Dea’s pain pill database. (2019, July 16). The Washington Post. Retrieved from https://www.washingtonpost.com/graphics/2019/investigations/dea-pain-pill-database/?utm_term=.07de4b1a18eb&amp;itid=lk_interstitial_manual_23.</li> 
    <li>Evans, W. N., Lieber, E. M., &amp; Power, P. (2019). How the reformulation of OxyContin ignited the heroin epidemic. The Review of Economics and Statistics, 101(1), 1–15. https://doi.org/10.1162/rest_a_00755 </li>
    <li>Evans, W. N., Lieber, E. M., &amp; Power, P. (2019). How the reformulation of OxyContin ignited the heroin epidemic. The Review of Economics and Statistics, 101(1), 1–15. https://doi.org/10.1162/rest_a_00755 </li>
    <li>Jick, H., &amp; Porter, J. (1980). Addiction rare in patients treated with narcotics. New England Journal of Medicine, 302(2), 123–123. https://doi.org/10.1056/nejm198001103020221 </li>
    <li>Macy, B. (2018). Dopesick: Dealers, doctors, and the company that addicted america. Little, Brown and Company. </li>
    <li>Meier, B. (2020). Pain Killer. Hachette Australia. </li>
    <li>Quinones, S. (2019). Dreamland. Bloomsbury Publishing. </li>
    <li>Van Zee, A. (2009). The promotion and marketing of Oxycontin: Commercial Triumph, public health tragedy. American Journal of Public Health, 99(2), 221–227. https://doi.org/10.2105/ajph.2007.131714 </li>
</ul>